A new nano-vaccine developed by TAU and the University of Lisbon offers a needle-free, room-temperature-storable solution against COVID-19, targeting all key variants effectively.
Professor Ronit Satchi-Fainaro's lab at Tel Aviv University's Faculty of Medical and Health Sciences has collaborated with Professor Helena Florindo's lab at the University of Lisbon to develop a novel nano-vaccine for COVID-19. This nano-vaccine, a 200-nanometer particle, effectively trains the immune system against all common COVID-19 variants, performing as well as existing vaccines.
Unlike other vaccines, it is conveniently administered as a nasal spray and does not require a cold supply chain or ultra-cold storage. These distinctive features pave the way for vaccinating populations in developing countries and the future development of simpler, more effective, and less expensive vaccines. The groundbreaking study was featured on the cover of the prestigious journal Advanced Science.
Development and Design of the Nano-Vaccine
Prof. Satchi-Fainaro explains: "The new nano-vaccine's development was inspired by a decade of research on cancer vaccines. When the COVID-19 pandemic began, we set a new goal: training our cancer platform to identify and target the coronavirus. Unlike Moderna and Pfizer, we did not rely on full protein expression via mRNA. Instead, using our computational bioinformatics tools, we identified two short and simple amino acid sequences in the virus's protein, then synthesized them, and encapsulated them in nanoparticles." Eventually, this nano-vaccine proved effective against all major variants of COVID-19, including Beta, Delta, Omicron, etc.
Benefits of the Nano-Vaccine: Needle-Free Administration
"Our nano-vaccine offers a significant advantage over existing vaccines because it is needle-free and administered as a nasal spray," notes Prof. Satchi-Fainaro. "This eliminates the need for skilled personnel such as nurses and technicians to administer injections, while also reducing risks of contamination and sharp waste. Anyone can use a nasal spray, with no prior training."
Advantages in Storage and Shipping
Another major advantage of the revolutionary nano-vaccine is its minimal storage requirements. Moderna's sensitive mRNA-based vaccine must be kept at -20°C and Pfizer's at -70°C, generating great logistic and technological challenges, such as shipping in special aircraft and ultra-cold storage – from the factory to the vaccination station.
Prof. Satchi-Fainaro's novel synthetic nanoparticles are far more durable and can be stored as a powder at room temperature. "There's no need for freezing or special handling," she says. "You just mix the powder with saline to create the spray. For testing purposes (as part of the EU's ISIDORe (Integrated Services for Infectious Disease Outbreak Research) feasibility program) we shipped the powder at room temperature to the INSERM infectious diseases lab in France. Their tests showed that our nano-vaccine is at least as effective as Pfizer's vaccine."
Future Implications and Expanding Applications
These important advantages—ease of nasal administration and regular storage and shipping — pave the way towards vaccinating at-risk populations in low-income countries and remote regions, which existing vaccines are unable to reach. Moreover, the novel platform opens the door for quickly synthesizing even more effective and affordable vaccines for future pandemics. "This is a plug-and-play technology," explains Prof. Satchi-Fainaro. "It can train the immune system to fight cancer or infectious diseases like COVID-19. We are currently expanding its use to target a range of additional diseases, enabling the rapid development of relevant new vaccines when needed."
Reference: "Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 Immunotherapy" by Rita C. Acúrcio, Ron Kleiner, Daniella Vaskovich-Koubi, Bárbara Carreira, Yulia Liubomirski, Carolina Palma, Adva Yeheskel, Eilam Yeini, Ana S. Viana, Vera Ferreira, Carlos Araújo, Michael Mor, Natalia T. Freund, Eran Bacharach, João Gonçalves, Mira Toister-Achituv, Manon Fabregue, Solene Matthieu, Capucine Guerry, Ana Zarubica, Sarit Aviel-Ronen, Helena F. Florindo and Ronit Satchi-Fainaro, 8 August 2024, Advanced Science.
DOI: 10.1002/advs.202404159
The groundbreaking project has received competitive research grants from the Israel Innovation Authority and Merck under the Nofar program, as well as funding from Spain's "La Caixa" Foundation Impulse as an accelerated program, and support from the ISIDORe feasibility program. It is also part of a broader vaccine platform development program at Professor Satchi-Fainaro's lab, supported by a European Research Council (ERC) Advanced Grant.
News
Study Finds 95% of Tested Beers Contain Toxic “Forever Chemicals”
Researchers found PFAS in 95% of tested beers, with the highest levels linked to contaminated local water sources. Per- and polyfluoroalkyl substances (PFAS), better known as forever chemicals, are gaining notoriety for their ability [...]
Long COVID Symptoms Are Closer To A Stroke Or Parkinson’s Disease Than Fatigue
When most people get sick with COVID-19 today, they think of it as a brief illness, similar to a cold. However, for a large number of people, the illness doesn't end there. The World [...]
The world’s first AI Hospital, developed in China is transforming healthcare
Artificial Intelligence and its developments have had a revolutionary impact on society, and healthcare is not an exception. China has made massive strides in AI integrated healthcare, and continues to do so as AI [...]
Scientists Rewire Immune Cells To Supercharge Cancer-Fighting Power
Blocking a single protein boosts T cell metabolism and tumor-fighting strength. The discovery could lead to next-generation cancer immunotherapies. Scientists have identified a strategy to greatly enhance the cancer-fighting abilities of the immune system’s [...]
Scientists Discover 20 Percent of Human DNA Comes from a Mysterious Ancestor
Humans carry a complex genetic history that continues to reveal surprises. Scientists have found that 20% of our DNA may come from a mysterious ancestor, according to WP Tech. This discovery changes how we understand [...]
AI detects early prostate cancer missed by pathologists
Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to find subtle tissue changes [...]
The Rare Mutation That Makes People Immune to Viruses
Some people carry a rare mutation that makes them resistant to viruses. Now scientists have copied that effect with an experimental mRNA therapy that stopped both flu and COVID in animal trials — raising [...]
Nanopore technique for measuring DNA damage could improve cancer therapy and radiological emergency response
Scientists at the National Institute of Standards and Technology (NIST) have developed a new technology for measuring how radiation damages DNA molecules. This novel technique, which passes DNA through tiny openings called nanopores, detects [...]
AI Tool Shows Exactly When Genes Turn On and Off
Summary: Researchers have developed an AI-powered tool called chronODE that models how genes turn on and off during brain development. By combining mathematics, machine learning, and genomic data, the method identifies exact “switching points” that [...]
Your brain could get bigger – not smaller – as you age
recently asked myself if I’ll still have a healthy brain as I get older. I hold a professorship at a neurology department. Nevertheless, it is difficult for me to judge if a particular brain, [...]
Hidden Cost of Smart AI: 50× More CO₂ for a Single Question
Every time we ask an AI a question, it doesn’t just return an answer—it also burns energy and emits carbon dioxide. German researchers found that some “thinking” AI models, which generate long, step-by-step reasoning [...]
Genetically-engineered immune cells show promise for preventing organ rejection
A Medical University of South Carolina team reports in Frontiers in Immunology that it has engineered a new type of genetically modified immune cell that can precisely target and neutralize antibody-producing cells complicit in organ rejection. [...]
Building and breaking plastics with light: Chemists rethink plastic recycling
What if recycling plastics were as simple as flicking a switch? At TU/e, Assistant Professor Fabian Eisenreich is making that vision a reality by using LED light to both create and break down a [...]
Generative AI Designs Novel Antibiotics That Defeat Defiant Drug-Resistant Superbugs
Harnessing generative AI, MIT scientists have created groundbreaking antibiotics with unique membrane-targeting mechanisms, offering fresh hope against two of the world’s most formidable drug-resistant pathogens. With the help of artificial intelligence, MIT researchers have [...]
AI finds more breast tumors earlier than traditional double radiologist review
AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by researchers led by Radboud [...]
Lavender oil could speed recovery after brain surgery
A week of lavender-scented nights helped brain surgery patients sleep more deeply, shorten delirium, and feel calmer, pointing to a simple, natural aid for post-surgery care. A randomized controlled trial investigating the therapeutic impact [...]
